HLA-DRA and COVID-19: The downregulation of class II major histocompatibility complex gene HLA-DRA is observed in multiple cell types and in both PBMCs and BALF of severe COVID-19 patients, including myeloid cells, B cells, T cells, NK cells and platelets.